Lion Point Capital’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Lion Point Capital’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-228,900	Closed	-$2.6M	–	38
2023 Q4	$2.6M	Buy	228,900 +146,442	+178%	+$1.15M	1.3%	7
2023 Q3	$332K	Buy	82,458 +36,807	+81%	+$273K	0.15%	26
2023 Q2	$324K	Buy	45,651 +28,723	+170%	+$199K	0.15%	25
2023 Q1	$126K	Buy	+16,928	New	+$142K	0.05%	28

Lion Point Capital's HARP Position: Q1 2024 in Review

Lion Point Capital sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 228,900 shares — an estimated $2.6M sold.

Lion Point Capital first reported a position in HARP in Q1 2023 and held it in 4 quarters. The position peaked at $2.6M in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Lion Point Capital reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Lion Point Capital sold 228,900 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.6M.
Lion Point Capital first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
Lion Point Capital's Harpoon Therapeutics, Inc. Common Stock position peaked at $2.6M in Q4 2023.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Lion Point Capital's 13F filing for Q1 2024, filed 15 May 2024.